Constitution Capital’s Elevance Health ELV Stock Holding History

Constitution Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,300	Closed	-$676K	–	59
2024 Q3	$676K	Hold	1,300	–	–	0.36%	32
2024 Q2	$704K	Hold	1,300	–	–	0.37%	33
2024 Q1	$674K	Hold	1,300	–	–	0.38%	34
2023 Q4	$613K	Sell	1,300 -300	-19%	-$139K	0.37%	32
2023 Q3	$697K	Sell	1,600 -150	-9%	-$68K	0.47%	31
2023 Q2	$778K	Hold	1,750	–	–	0.44%	31
2023 Q1	$805K	Hold	1,750	–	–	0.49%	32
2022 Q4	$898K	Hold	1,750	–	–	0.55%	31
2022 Q3	$795K	Buy	1,750 +1,100	+169%	+$526K	0.53%	31
2022 Q2	$314K	Hold	650	–	–	0.2%	45
2022 Q1	$319K	Sell	650 -100	-13%	-$45.7K	0.17%	48
2021 Q4	$348K	Sell	750 -100	-12%	-$42.1K	0.19%	43
2021 Q3	$317K	Hold	850	–	–	0.19%	48
2021 Q2	$325K	Hold	850	–	–	0.2%	49
2021 Q1	$305K	Hold	850	–	–	0.2%	46
2020 Q4	$273K	Buy	+850	New	+$261K	0.19%	47

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Constitution Capital's ELV Position: Q4 2024 in Review

Constitution Capital sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 1,300 shares — an estimated $676K sold.

Constitution Capital first reported a position in ELV in Q4 2020 and held it in 16 quarters. The position peaked at $898K in Q4 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

Constitution Capital reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
Constitution Capital sold 1,300 Elevance Health shares in Q4 2024, an estimated $676K.
Constitution Capital first reported a position in Elevance Health in Q4 2020 and held it in 16 quarters.
Constitution Capital's Elevance Health position peaked at $898K in Q4 2022.
1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Constitution Capital's 13F filing for Q4 2024, filed 15 Jan 2025.